MDXG
Price
$6.33
Change
-$0.08 (-1.25%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
935.69M
61 days until earnings call
OMER
Price
$3.30
Change
-$0.04 (-1.20%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
193.36M
62 days until earnings call
Interact to see
Advertisement

MDXG vs OMER

Header iconMDXG vs OMER Comparison
Open Charts MDXG vs OMERBanner chart's image
MiMedx Group
Price$6.33
Change-$0.08 (-1.25%)
Volume$7.19K
Capitalization935.69M
Omeros
Price$3.30
Change-$0.04 (-1.20%)
Volume$20.27K
Capitalization193.36M
MDXG vs OMER Comparison Chart
Loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXG vs. OMER commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXG is a Hold and OMER is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (MDXG: $6.42 vs. OMER: $3.34)
Brand notoriety: MDXG and OMER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXG: 58% vs. OMER: 82%
Market capitalization -- MDXG: $948.25M vs. OMER: $195.7M
MDXG [@Biotechnology] is valued at $948.25M. OMER’s [@Biotechnology] market capitalization is $195.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXG’s FA Score shows that 1 FA rating(s) are green whileOMER’s FA Score has 1 green FA rating(s).

  • MDXG’s FA Score: 1 green, 4 red.
  • OMER’s FA Score: 1 green, 4 red.
According to our system of comparison, MDXG is a better buy in the long-term than OMER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXG’s TA Score shows that 4 TA indicator(s) are bullish while OMER’s TA Score has 6 bullish TA indicator(s).

  • MDXG’s TA Score: 4 bullish, 6 bearish.
  • OMER’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OMER is a better buy in the short-term than MDXG.

Price Growth

MDXG (@Biotechnology) experienced а -1.38% price change this week, while OMER (@Biotechnology) price change was +5.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

MDXG is expected to report earnings on Aug 05, 2025.

OMER is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXG($936M) has a higher market cap than OMER($193M). MDXG YTD gains are higher at: -33.264 vs. OMER (-66.194). MDXG has higher annual earnings (EBITDA): 62.1M vs. OMER (-155.96M). OMER has more cash in the bank: 123M vs. MDXG (106M). MDXG has less debt than OMER: MDXG (18.7M) vs OMER (209M). MDXG has higher revenues than OMER: MDXG (352M) vs OMER (0).
MDXGOMERMDXG / OMER
Capitalization936M193M485%
EBITDA62.1M-155.96M-40%
Gain YTD-33.264-66.19450%
P/E Ratio23.46N/A-
Revenue352M0-
Total Cash106M123M86%
Total Debt18.7M209M9%
FUNDAMENTALS RATINGS
MDXG vs OMER: Fundamental Ratings
MDXG
OMER
OUTLOOK RATING
1..100
753
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
4111
PRICE GROWTH RATING
1..100
6397
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OMER's Valuation (45) in the Biotechnology industry is in the same range as MDXG (67). This means that OMER’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as OMER (100). This means that MDXG’s stock grew similarly to OMER’s over the last 12 months.

OMER's SMR Rating (11) in the Biotechnology industry is in the same range as MDXG (41). This means that OMER’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's Price Growth Rating (63) in the Biotechnology industry is somewhat better than the same rating for OMER (97). This means that MDXG’s stock grew somewhat faster than OMER’s over the last 12 months.

MDXG's P/E Growth Rating (12) in the Biotechnology industry is significantly better than the same rating for OMER (100). This means that MDXG’s stock grew significantly faster than OMER’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDXGOMER
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WGGNX11.12N/A
N/A
William Blair Global Leaders N
FGDTX36.55N/A
N/A
Fidelity Advisor Gold M
PQSAX25.02N/A
N/A
Virtus KAR Small-Cap Value A
WFPRX47.42N/A
N/A
Allspring Special Mid Cap Value R6
GCPAX19.70N/A
N/A
Gateway Equity Call Premium A

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-0.93%
AXON - MDXG
47%
Loosely correlated
+2.76%
VCYT - MDXG
42%
Loosely correlated
+2.98%
ARRY - MDXG
39%
Loosely correlated
-0.43%
RAPT - MDXG
38%
Loosely correlated
+3.24%
INM - MDXG
38%
Loosely correlated
-10.24%
More

OMER and

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
+6.37%
VCYT - OMER
40%
Loosely correlated
+2.98%
INM - OMER
36%
Loosely correlated
-10.24%
MDXG - OMER
33%
Loosely correlated
-0.93%
FULC - OMER
31%
Poorly correlated
-0.07%
KYMR - OMER
31%
Poorly correlated
+1.56%
More